CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features.
about
ALK Signaling and Target Therapy in Anaplastic Large Cell LymphomaAnaplastic lymphoma kinase: signalling in development and diseaseEML4-ALK rearrangement in non-small cell lung cancer and non-tumor lung tissuesPrimary systemic anaplastic large cell lymphoma in Korean adults: 11 years' experience at Asan Medical CenterDiversity of genomic breakpoints in TFG-ALK translocations in anaplastic large cell lymphomas: identification of a new TFG-ALK(XL) chimeric gene with transforming activitySarcomatoid variant of ALK- anaplastic large cell lymphoma involving multiple lymph nodes and both lungs with production of proinflammatory cytokines: report of a case and review of literatureAntibody Drug Conjugates: Preclinical ConsiderationsCD30+ Lymphoproliferative Disorders of the Skin.NPM/ALK binds and phosphorylates the RNA/DNA-binding protein PSF in anaplastic large-cell lymphoma.High expression of Mcl-1 in ALK positive and negative anaplastic large cell lymphoma.Classification of lymphoid neoplasms: the microscope as a tool for disease discovery.The heterogeneous landscape of ALK negative ALCL.Anaplastic cutaneous lymphoma mimicking an infection.A novel, highly sensitive antibody allows for the routine detection of ALK-rearranged lung adenocarcinomas by standard immunohistochemistry.PAX5-positive T-cell anaplastic large cell lymphomas associated with extra copies of the PAX5 gene locusALK-rearrangements and testing methods in non-small cell lung cancer: a reviewNanopharmacology in translational hematology and oncologySynergistic growth inhibition of anaplastic large cell lymphoma cells by combining cellular ALK gene silencing and a low dose of the kinase inhibitor U0126Extranodal anaplastic large cell lymphoma mimicking sarcoma: A report of an interesting case.A nanocomplex that is both tumor cell-selective and cancer gene-specific for anaplastic large cell lymphomaFlow cytometry as a diagnostic tool in the early diagnosis of aggressive lymphomas mimicking life-threatening infection.Locally advanced breast implant-associated anaplastic large-cell lymphoma: a case report of successful treatment with radiation and chemotherapy.Genomic profiling of peripheral T-cell lymphoma, unspecified, and anaplastic large T-cell lymphoma delineates novel recurrent chromosomal alterationsPrimary cutaneous CD30+ anaplastic large cell lymphoma: report of a rare caseCrizotinib (PF-2341066) induces apoptosis due to downregulation of pSTAT3 and BCL-2 family proteins in NPM-ALK(+) anaplastic large cell lymphomaRole of mucins in the skin during benign and malignant conditions.Anaplastic lymphoma kinase-positive anaplastic large-cell lymphoma with involvement of the urinary bladder: a case report and review of literature.Revised International Pediatric Non-Hodgkin Lymphoma Staging System.Chromosomal gains at 9q characterize enteropathy-type T-cell lymphomaEffective therapy for a murine model of human anaplastic large-cell lymphoma with the anti-CD30 monoclonal antibody, HeFi-1, does not require activating Fc receptorsCase report: A unique pediatric case of a primary CD8 expressing ALK-1 positive anaplastic large cell lymphoma of skeletal musclePathobiology of ALK+ anaplastic large-cell lymphoma.Unveiling Cancer.ALK-immunoreactive neoplasms.ALK+ anaplastic large cell lymphoma exhibits phosphatidylinositol-3 kinase/Akt activity with retained but inactivated PTEN--a report from the Children's Oncology Group.Best Practice No 185. Cytological and molecular diagnosis of lymphoma.Sensitivity Analysis of the NPM-ALK Signalling Network Reveals Important Pathways for Anaplastic Large Cell Lymphoma Combination Therapy.Clinical and laboratory characteristics of systemic anaplastic large cell lymphoma in Chinese patientsPrimary anaplastic large-cell lymphoma associated with breast implants.Constitutive control of AKT1 gene expression by JUNB/CJUN in ALK+ anaplastic large-cell lymphoma: a novel crosstalk mechanism.
P2860
Q21129306-F353FB8F-FFCD-4E9C-84CE-595618C7AEE3Q24312329-AF109389-D3CB-4322-BEE6-3E49278E09F2Q24645724-F3D79629-238B-48D5-A223-20B7967CE9E8Q24652793-B734D211-DA54-402D-A282-4A2DF5DDFDE1Q24669845-042C04F8-C3B4-44E2-80D6-EED66E6ECF28Q26860515-355EFA09-73F7-41AC-802A-9F6E16F61FADQ27022321-A1F0C944-2AEB-478F-8B6C-88BB783DF29DQ30235097-837A648A-A910-4EEA-8A9B-9CE346990BDEQ30831857-19B2A5EF-A967-4223-B4F3-E8A732DA2D91Q31164878-D7131892-D053-494D-8E50-FB17E0CC54DDQ33386690-E8A4309C-949C-4828-9682-904DB195B1ACQ33567012-92E44A00-7841-49AA-BD19-18CBA9441964Q33670860-8C8A0ACB-2BC0-4CBD-9D35-3980B07FA964Q33699169-B9B4A463-F1A1-4EA3-A0C1-428E461EAFBBQ33766227-DB3018B4-AF0A-4995-BC30-7E9640D84430Q33776835-40045695-E898-46FA-8A83-12678792A433Q33961538-285FD445-2C51-4C2B-81E6-A5ED5F6CA60AQ34057987-A8594FC3-8486-4C8D-8076-E0B7908A81DCQ34272033-144AEB97-5B35-4371-B1E8-BDFB436F350BQ34607749-245E2208-ABAA-4E09-8B01-16CEA31B6505Q35043982-1E7A8D30-68CA-400F-960F-496E38751D88Q35092826-016169A0-D7AF-4924-851D-D9940305F8DFQ35098010-316D9EDC-754A-469E-9119-E95BBED6ADB1Q35169738-3F8FAD1F-48D2-48F4-BF09-05E379474DD2Q35285497-30799915-E33D-49D6-BA9C-E1B86B7C80AEQ35596376-5F3316E3-D670-4953-B301-BB85B0F4D306Q35654950-90F8F27A-FC6B-400D-87E5-A60687EB4D9BQ35708778-2FF139F0-F7CC-4A51-9753-84F036D71253Q35747806-DE43BA55-D98D-4126-A684-13D142F59E64Q35848928-AB06ABBC-052F-472D-A687-1D29F1FE8C0EQ35984463-C5661EFD-EB79-474D-AF2E-11FF254A9F8FQ36007756-F32BB888-BF79-418A-A2C2-83FB013684D6Q36009904-B5984653-D20F-4FB3-A8F8-BAE902798F8EQ36092957-1891C381-2924-4D2D-8B2F-3A9FB7EA33D6Q36094893-554DF16A-DACE-47A5-BBCE-74E3516B7207Q36139880-A2F0783F-FBB5-4837-8135-01E4B249B686Q36145016-B7689D41-BF98-4979-94A6-58F30F9D6752Q36162589-E41CEC49-C18A-4CA9-8D29-0E0C3E961D8BQ36206809-C05FE17D-A993-4A28-BE20-9E5D618934CAQ36248978-E39DAD3B-B33C-4793-A83E-887CB84F9D22
P2860
CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features.
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
CD30(+) anaplastic large cell ...... enetic, and clinical features.
@ast
CD30(+) anaplastic large cell ...... enetic, and clinical features.
@en
CD30(+) anaplastic large cell ...... enetic, and clinical features.
@nl
type
label
CD30(+) anaplastic large cell ...... enetic, and clinical features.
@ast
CD30(+) anaplastic large cell ...... enetic, and clinical features.
@en
CD30(+) anaplastic large cell ...... enetic, and clinical features.
@nl
prefLabel
CD30(+) anaplastic large cell ...... enetic, and clinical features.
@ast
CD30(+) anaplastic large cell ...... enetic, and clinical features.
@en
CD30(+) anaplastic large cell ...... enetic, and clinical features.
@nl
P2093
P1433
P1476
CD30(+) anaplastic large cell ...... enetic, and clinical features.
@en
P2093
Marafioti T
P304
P407
P577
2000-12-01T00:00:00Z